Buy & Sell Cytokinetics Inc (CYTK) – Cytokinetics Inc Price Today
Supreme Court rejects Eli Lilly's appeal, upholding $194M Medicaid fraud judgment.
The U.S. Supreme Court declined to hear Eli Lilly's appeal, leaving a $194 million whistleblower judgment intact. The case involved allegations that Eli Lilly underreported drug pricing to reduce Medicaid rebate payments by about $61 million. The rul...
Myasthenia gravis market to exceed $16B by 2036 driven by rising diagnoses and new targeted biologics.
The myasthenia gravis market, valued at around $6 billion in 2025, is projected to grow at a 9.1% CAGR to surpass $16 billion by 2036. Growth is fueled by increasing diagnosed cases, especially among older populations, and a surge in innovative targe...
BlackRock's stake in Fagron briefly rises above 3% before dropping below again.
BlackRock, Inc. disclosed two transparency notifications regarding its holdings in Fagron NV. On May 11, 2026, BlackRock's stake in Fagron rose above the 3% threshold, holding 3.01% of voting rights with 2,072,188 shares plus 145,030 financial instru...
Brodsky & Smith investigates fiduciary duty breaches in merger deals of Dominion Energy, Global Business Travel, Webster Financial, and TopBuild.
Brodsky & Smith LLC has announced investigations into whether the boards of Dominion Energy, Global Business Travel Group, Webster Financial, and TopBuild breached their fiduciary duties to shareholders during recent merger agreements. These probes f...
Japanese partner urges caution on Tavneos use amid safety concerns and FDA scrutiny.
Kissei Pharmaceutical, Amgen's Japanese partner, has advised doctors to exercise caution when prescribing Tavneos (avacopan) due to safety concerns, including risks of liver dysfunction. This follows FDA warnings and a proposed withdrawal of Tavneos ...
Pepeto presale nears Binance listing, promising bigger returns than XRP's forecasted growth.
Pepeto is preparing for a Binance listing amid a forming crypto bull run, with its presale raising over $10 million and showing strong community growth. The project offers a zero-fee exchange with AI contract screening and cross-chain capabilities, a...
ImmunityBio gains exclusive U.S. rights to Tokyo-172 BCG for bladder cancer after positive Phase 3 trial.
ImmunityBio secured exclusive U.S. development and supply rights for the Tokyo-172 strain of BCG, an investigational bladder cancer therapy not yet FDA-approved. This follows positive Phase 3 trial results showing Tokyo-172 BCG is as effective as the...
Volatility rises across assets as bond yields hit 1-year high on inflation fears
Implied volatility increased across multiple asset classes last week, driven by a spike in bond yields due to rising inflation expectations. The US 10-year Treasury yield reached a one-year high of 4.6%, pushing volatility indexes like the Russell 20...
US tech valuations driven by AI hype face correction; shift to UK value and selective China stocks advised
US tech stocks, especially those linked to AI, are currently overvalued due to overly optimistic assumptions about compute scarcity and capital expenditure growth. The author recommends reducing exposure to these overvalued US tech stocks and instead...
Microsoft stock looks attractive after a selloff, with Bill Ackman buying amid strong AI growth and solid fundamentals.
Microsoft's stock has dropped 11% this year despite its AI business growing over 100% annually and strong Azure cloud growth. Investor Bill Ackman is increasing his Microsoft holdings while reducing Alphabet, seeing value in Microsoft's current price...